These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6633451)

  • 1. [Staphylocidal activity of Stanicide-fusidinic acid in vitro and its use in the therapy of the nasal staphylococcal carrier state by local administration].
    Bozović M; Nastov D
    Med Pregl; 1983; 36(5-6):205-6. PubMed ID: 6633451
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal carriage of sodium fusidate resistant Staphylococcus aureus.
    Dealler S
    J R Coll Gen Pract; 1988 Apr; 38(309):171. PubMed ID: 3216357
    [No Abstract]   [Full Text] [Related]  

  • 3. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
    Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
    Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal carriage and antibiotic susceptibility of Staphylococcus aureus in general practice.
    Gillett AP; Johnson T; Orton C; Wills R; Menday AP; Talbot DJ
    J R Coll Gen Pract; 1984 May; 34(262):255-7. PubMed ID: 6737360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusidic acid resistance in Staphylococcus aureus isolates.
    Brown EM; Thomas P
    Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
    [No Abstract]   [Full Text] [Related]  

  • 6. What should be done with nasal Staphylococcus aureus carriers?
    Kampf G
    J Hosp Infect; 2005 Dec; 61(4):353-4. PubMed ID: 16242810
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
    Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
    García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
    Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Fucidin.
    Dealler S; Fraser AK
    J R Coll Gen Pract; 1986 Mar; 36(284):136. PubMed ID: 3712354
    [No Abstract]   [Full Text] [Related]  

  • 10. Accurate assessment of heterogeneous vancomycin-intermediate Staphylococcus aureus nasal carriage.
    Charles PG; Howden BP; Ward PB; Bishop EJ; Johnson PD; Grayson ML
    Clin Infect Dis; 2005 Oct; 41(7):1071-2; author reply 1072-3. PubMed ID: 16142682
    [No Abstract]   [Full Text] [Related]  

  • 11. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
    Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
    Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of fusidic acid against methicillin-resistant Staphylococcus aureus.
    Erdenizmenli M; Yapar N; Sengönül A; Yüce A; Cakir N; Yulug N
    J Chemother; 2004 Jun; 16(3):310-1. PubMed ID: 15330332
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nasal carriage of Staphylococcus aureus in hospital personnel and the normal population and antibiotic resistance of the isolates].
    Yazgi H; Ertek M; Ozbek A; Kadanali A
    Mikrobiyol Bul; 2003; 37(2-3):137-42. PubMed ID: 14593895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
    Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
    Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
    Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
    Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal carriage of Staphylococcus aureus in healthy preschool children.
    Oguzkaya-Artan M; Baykan Z; Artan C
    Jpn J Infect Dis; 2008 Jan; 61(1):70-2. PubMed ID: 18219139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusidic acid as a potential antistaphylococcal agent.
    Nicholson J; Chew T; Smith S
    N Z Med J; 1999 Jul; 112(1091):261-2. PubMed ID: 10448991
    [No Abstract]   [Full Text] [Related]  

  • 19. Nasal carriage of staphylococci in health care workers: antimicrobial susceptibility profile.
    Farzana K; Rashid Z; Akhtar N; Sattar A; Khan JA; Nasir B
    Pak J Pharm Sci; 2008 Jul; 21(3):290-4. PubMed ID: 18614427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
    Mason BW; Howard AJ
    Int J Antimicrob Agents; 2004 Mar; 23(3):300-3. PubMed ID: 15164973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.